Brain metastases from breast cancer: Lessons from experimental magnetic resonance imaging studies and clinical implications

Journal of Molecular Medicine

Volumn 92, Issue 1, 2014, Pages 5-12

  Murrell, Donna H ^a,b   Foster, Paula J ^a,b   Chambers, Ann F ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Breast cancer; Dormancy; Iron; Metastasis; MRI; Nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT;

BLOOD BRAIN BARRIER; BRAIN METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; DORMANCY; HUMAN; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY; REVIEW;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84891882638     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1108-z     Document Type: Review

References (58)

1. Breast Cancer Facts 2013. http://www.nationalbreastcancer.org/breast- cancer-facts. Accessed 16 Oct 2013
2. Canadian Cancer Statistics 2013. http://www.cancer.ca. Accessed 3 Sept 2013
3. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11-30
4. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572 (Pubitemid 37328923)
5. Maxmen A (2012) The hard facts. Nature 485:S50-S51
6. Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159-211 (Pubitemid 20088338)
7. Tarin D, Vass AC, Kettlewell MG, Price JE (1984) Absence of metastatic sequelae during long-term treatment of malignant ascites by peritoneo-venous shunting. A clinic-pathological report. Invas Metast 4:1-12 (Pubitemid 14168892)
8. Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44:3584-3592 (Pubitemid 14098615)
9. Goss PE, Chambers AF (2010) Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 10(12):871-877
10. Canadian Cancer Statistics 2010. http://www.cancer.ca Accessed Feb 2010
11. Sharma M, Abraham J (2007) CNS metastasis in primary breast cancer. Expert Rev Anticancer Ther 7(11):1561-1566 (Pubitemid 350303013)
12. Kirsch DG, Loeffler JS (2005) Brain metastases in patients with breast cancer: new horizons. Clin Breast Cancer 2:115-124 (Pubitemid 40975607)
13. Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J et al (2006) Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol 17(6):935-944 (Pubitemid 43778983)
14. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008) Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 113(10):2638-2645
15. Sperduto PW, Kased N, Roberge D, XU Z, Shanley R, Luo X, Sneed P, Chao ST et al (2012) Effect of tumor subtype on survival and the graded prognostic assessment for patients breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82(5):2111-2117
16. Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL, Shaw EG et al (2012) Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol 110(3):381-388
17. MacDonald IC, Chambers AF (2006) Breast cancer metastasis progression as revealed by intravital videomicroscopy. Expert Rev Anticancer Ther 6:1271-1279 (Pubitemid 44575579)
18. Allan AL, Vantyghem SA, Tuck AB, Chambers AF (2006-2007) Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. Breast Dis 26:87-89
19. Barkan D, Chambers AF (2011) β1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin Cancer Res 17(23):7219-7223
20. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807-817
21. Sosa MS, Bragado P, Debnath J, Aguirre-Ghiso JA (2013) Regulation of tumor cell dormancy by tissue microenvironments and autophagy. Adv Exp Med Biol 734:73-89
22. Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VHC, Groom AC, Chambers AF (2003) Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 82(3):199-206 (Pubitemid 37521976)
23. Townson JT, Ramadan SS, Simedrea C, Rutt BK, MacDonald IC, Foster PJ, Chambers AF (2009) Three-dimensional imaging and quantification of both solitary cells and metastases in whole mouse liver by magnetic resonance imaging. Cancer Res 69(21):8326-8331
24. Ohno S, Ishida M, Kataoka A, Murakami S (2004) Brain metastasis of breast cancer. Breast Cancer 11(1):27-29
25. Mokbel K, Hassanally D (2001) From HER2 to herceptin. Curr Med Res Opin 17(1):51-59 (Pubitemid 32594973)
26. Baselga J, Albanell J (2001) Mechanism of action of anti-HER2 monoclonal antibodies. Ann Oncol 12(Suppl1):S35-S41
27. Daniele L, Sapino A (2009) Anti-HER2 treatment and breast cancer: state of the art, recent patents and new strategies. Recent Pat Anticancer Drug Discov 4(1):9-18 (10)
28. Gonzalez-Angulo AM, Hortobagyi GN, Esteva FJ (2006) Adjuvant therapy with trastuzumab for HER2/neu-positive breast cancer. Oncologist 11(8):857-867 (Pubitemid 44373758)
29. Pieńkowski T, Zielinski CC (2010) Trastuzumab treatment in patients with breast cancer and metastatic CNS disease. Ann Oncol 21(5):917-924
30. Shmueli E, Wigler N, Inbar M (2004) Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. Eur J Cancer 40(3):379-382 (Pubitemid 38121275)
31. Clayton A, Danson S, Jolly S, Ryder W, Burt P, Stewart A et al (2004) Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 91:639-643 (Pubitemid 39141617)
32. Lower E, Blau R, Bismayer J, Brennan L, Broun R, Dannenman W et al (2001) Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin. Breast Cancer Res Treat 69:271 (Pubitemid 33789093)
33. Son CH, Jimenez R, Niemierko A, Loeffler JS, Oh KS, Shih HA (2012) Outcomes after whole brain reirradiation in patients with brain metastases. Int J Radiat Oncol Biol Phys 82(2):e167-e172
34. Anzalone N, Gerevini S, Scotti R, Vezzulli P, Picozzi P (2009) Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. Acta Radiol 50(8):933-940
35. Runge VM, Ai T, Hao D, Hu X (2011) The developmental history of the use of gadolinium chelates as intravenous contrast media for MRI. Invest Radiol 46(12):807
36. van der Molen AJ, Bellin MF (2008) Extracellular gadolinium-based contrast media. Eur J Radiol 66(2):168-174
37. Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16(4):407-422 (Pubitemid 35167876)
38. Schaefer PW, Grant PE, Gonzalez RG (2000) Diffusion-weighted MR imaging of the brain. Radiology 217:331-345
39. Rye PD, Norum L, Olsen DR et al (1996) Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11. Int J Cancer 68(5):682-687 (Pubitemid 26414532)
40. Yoneda T, Williams PJ, Hiraga T et al (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16(8):1486-1495 (Pubitemid 32675200)
41. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D et al (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67(9):4190-4198 (Pubitemid 46815065)
42. Tanner M, Kapanen AI, Raheem O, Grenman S, Elo J, Elenius K, Isola J (2004) Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther 3(12):1585-1592 (Pubitemid 40136714)
43. Quintana A, Raczka E, Bonaccorsi A (1979) Cardiac output distribution measured with radioactive microspheres in the mouse. Pharmacol Res Commun 11(3):245-252 (Pubitemid 9159228)
44. Basse P, Hokland P, Heron I, Hokland M (1988) Fate of tumour cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst 80(9):657-665
45. Perera M, Ribot EJ, Percy DB, McFadden C, Simedrea C, Palmieri D, Chambers AF, Foster PJ (2012) In vivo magnetic resonance imaging for investigating the development and distribution of experimental brain metastases due to breast cancer. Transl Oncol 5(3):1-9
46. Heyn C, Ronald JA, Mackenzie LT, MacDonald IC, Chambers AF, Rutt BK, Foster PJ (2006) In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55:23-29 (Pubitemid 43062924)
47. Gonzales-Lara LE, Xu X, Hofstetrova K, Pniak A, Chen Y, McFadden C, Martinez-Santiesteban FM, Rutt BK, Brown A, Foster PJ (2011) The use of cellular magnetic resonance imaging to track the fate of iron-labelled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Mol Imaging Biol 13(4):702-711
48. Noad J, Gonzales-Lara LE, Broughton HC, McFadden C, Chen Y, Hess DA, Foster PJ (2013) MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia. NMR Biomed 26(4):458-467
49. Lu S, Liu S, Zu Q, Xu X, Yu J, Wang J, Zhang Y, Shi H (2013) In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke model. PLoS ONE 8(2):e54963
50. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS et al (2006) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56:1001-1010 (Pubitemid 44691342)
51. Zhang RD, Price JE, Fujimaki T et al (1992) Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am J Pathol 141:1115-1124
52. Lockman PR, Mittapalli RK, Taskar KS et al (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16:5664-5678
53. Percy DB, Ribot EJ, Chen Y, McFadden C, Simedrea C, Steeg PS, Chambers AF, Foster PJ (2011) In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach. Invest Radiol 46(11):718-725
54. Hermanek P, Hutter RV, Sobin LH, Wittekind C (1999) Classification of isolated tumor cells and micrometastasis. Cancer 86:2668-2673 (Pubitemid 30004671)
55. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Marksbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. New Engl J Med 322:494-500 (Pubitemid 20067825)
56. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain - A randomized trial. J Amer Med Assoc 280(17):1485-1489 (Pubitemid 28507400)
57. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase ΙΙΙ results of the RTOG 9508 randomised trial. Lancet 363:1665-1672 (Pubitemid 38670323)
58. Huang F, Alrefae M, Langleben A, Roberge D (2009) Prophylactic cranial irradiation in advanced breast cancer: a case for caution. Int J Radiat Oncol 73(3):752-758